LTR Pharma (ASX:LTP) Pre-Tax Income : A$ Mil (TTM As of Jun. 2023)

View and export this data going back to 2023. Start your Free Trial

What is LTR Pharma Pre-Tax Income?

Pretax income is the income that a company earns before paying income taxes. LTR Pharma's pretax income for the six months ended in Jun. 2023 was A$-1.46 Mil. LTR Pharma does not have enough years/quarters to calculate the pretax income for the trailing twelve months (TTM) ended in Jun. 2023. LTR Pharma's pretax margin was %.

LTR Pharma Pre-Tax Income Historical Data

The historical data trend for LTR Pharma's Pre-Tax Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

LTR Pharma Pre-Tax Income Chart

LTR Pharma Annual Data

Trend

Jun21

Jun22

Jun23

Pre-Tax Income

-0.04

-1.03

-1.46

LTR Pharma Semi-Annual Data
	Jun21	Jun22	Jun23
Pre-Tax Income	-0.04	-1.03	-1.46

Competitive Comparison of LTR Pharma's Pre-Tax Income

For the Biotechnology subindustry, LTR Pharma's Pre-Tax Income, along with its competitors' market caps and Pre-Tax Income data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

LTR Pharma's Pre-Tax Income Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, LTR Pharma's Pre-Tax Income distribution charts can be found below:

* The bar in red indicates where LTR Pharma's Pre-Tax Income falls into.

LTR Pharma Pre-Tax Income Calculation

This is the income that a company earns before paying income taxes.

LTR Pharma's Pretax Income for the fiscal year that ended in Jun. 2023 is calculated as

Pretax Income	=	Operating Income	+	Non Operating Income	+	Interest Expense	+	Interest Income	+	Other
	=	-1.436	+	-0.019	+	0	+	0	+	-2.2204460492503E-16
	=	-1.46

LTR Pharma's Pretax Income for the quarter that ended in Jun. 2023 is calculated as

Pretax Income	=	Operating Income	+	Non Operating Income	+	Interest Expense	+	Interest Income	+	Other
	=	-1.436	+	-0.019	+	0	+	0	+	-2.2204460492503E-16
	=	-1.46

LTR Pharma (ASX:LTP) Pre-Tax Income Explanation

LTR Pharma's Pretax Margin for the quarter that ended in Jun. 2023 is calculated as

Pretax Margin	=	Pretax Income	/	Revenue
	=	-1.455	/	0
	=	%

LTR Pharma Pre-Tax Income Related Terms

Thank you for viewing the detailed overview of LTR Pharma's Pre-Tax Income provided by GuruFocus.com. Please click on the following links to see related term pages.

LTR Pharma (ASX:LTP) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » LTR Pharma Ltd (ASX:LTP) » Definitions » Pre-Tax Income

Comparable Companies

Traded in Other Exchanges

N/A

Address

9A/204 Alice Street, Brisbane, QLD, AUS, 4000

Website

https://www.ltrpharma.com

LTR Pharma Ltd is a clinical stage pharmaceutical company focused on holistically improving men's health, physically and mentally, through the commercialization of an intranasal spray treatment for Erectile Dysfunction. SPONTAN is a Vardenafil-based nasal delivery formulation designed to be a lower dose fast-acting administration that provides a rapid and high availability to a patient's bloodstream compared with the incumbent oral ED treatment products on market.

LTR Pharma (ASX:LTP) Headlines

No Headlines